This inventor holds 4 USPTO granted patents. Top assignees: Medical Research Council, Other. Active years: 2001-2003.
Company Filing History:
3 out of 259 
1 out of 834,411 Years Active: 2001-2003
Title: Christopher J Ward: Innovator in Genetic Research
Introduction
Christopher J Ward is a notable inventor based in Oxford, GB. He has made significant contributions to the field of genetic research, particularly in relation to polycystic kidney disease. With a total of 4 patents to his name, Ward's work has implications for disease diagnosis and therapy.
Latest Patents
Ward's latest patents include groundbreaking inventions related to the polycystic kidney disease 1 (PKD1) gene. The first patent, titled "Polycystic kidney disease 12 gene and uses thereof," focuses on the PKD1 gene and its nucleic acid sequence. It addresses mutations in patients with PKD1-associated disorders and explores the protein encoded by the PKD1 gene or its mutants, along with their applications in disease diagnosis and therapy. The second patent, "Polycystic kidney disease 1 gene and uses thereof," shares similar themes, emphasizing the importance of the PKD1 gene in understanding and treating this condition.
Career Highlights
Throughout his career, Ward has been associated with the Medical Research Council, where he has contributed to various research initiatives. His work has been pivotal in advancing the understanding of genetic disorders and their implications for patient care.
Collaborations
Ward has collaborated with esteemed colleagues, including Peter Charles Harris and Martin Hendrik Breuning. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Christopher J Ward stands out as an influential figure in genetic research, particularly in the study of polycystic kidney disease. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.